These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 4051899)
21. [Clinical trials with Fonlipol. Apropos of 50 cases]. Warembourg H; Jaillard J Lille Med; 1974 Apr; 19(4 Suppl 11):528-31. PubMed ID: 4612282 [No Abstract] [Full Text] [Related]
22. The primary hyperlipoproteinemias. Bybee DE; Hamilton RD J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515 [No Abstract] [Full Text] [Related]
23. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. Fodor JG; Frohlich JJ; Genest JJ; McPherson PR CMAJ; 2000 May; 162(10):1441-7. PubMed ID: 10834048 [No Abstract] [Full Text] [Related]
24. [Clinical experimentation of clofibride. Apropos of 40 cases]. Warembourg H; Jaillard J Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928 [No Abstract] [Full Text] [Related]
25. Does hypolipidemic therapy prevent coronary heart disease? Rifkind BM; Levy RI Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303 [No Abstract] [Full Text] [Related]
26. [Clinical trial of tibric acid, a new hypolipidemic agent]. Noseda G; Sirtori CR Schweiz Med Wochenschr; 1974 Dec; 104(51):1917-22. PubMed ID: 4438990 [No Abstract] [Full Text] [Related]
28. [Drug therapy of dyslipidemias]. Fonda M; Cattin L; Guarnieri G Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924 [No Abstract] [Full Text] [Related]
29. Lipid-lowering therapy and its effect on atherosclerosis. Thompson GR Postgrad Med J; 1989; 65 Suppl 1():S22-5. PubMed ID: 2695906 [No Abstract] [Full Text] [Related]
30. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)]. Fourrier A; Mouton Y Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283 [No Abstract] [Full Text] [Related]
31. The effect on serum tocopherol levels of drug-induced decrease in serum lipids. Weiss P; Bianchine JR Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464 [No Abstract] [Full Text] [Related]
33. Lipid disorders: applying new guidelines to your older patients. Leaf DA Geriatrics; 1994 May; 49(5):35-41. PubMed ID: 8174939 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of lipid metabolism disorders in the elderly]. Mizera W; Grzeszczak W Wiad Lek; 1998; 51 Suppl 2():52-7. PubMed ID: 9686534 [TBL] [Abstract][Full Text] [Related]
35. The role of lipid lowering in transplantation. Wierzbicki AS Int J Clin Pract; 1999; 53(1):54-9. PubMed ID: 10344068 [TBL] [Abstract][Full Text] [Related]
36. [Dyslipidemia: what every physician should keep in mind]. Jambart S J Med Liban; 1993; 41(3):139-42. PubMed ID: 7799414 [No Abstract] [Full Text] [Related]
37. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia. Wolf HR Drugs Exp Clin Res; 1994; 20(3):109-13. PubMed ID: 7956717 [TBL] [Abstract][Full Text] [Related]
39. [Management of hyperlipidemia: diet and drugs are complementary to each other]. Olsson A Lakartidningen; 1989 Feb; 86(5):316-7. PubMed ID: 2915581 [No Abstract] [Full Text] [Related]